US 11426420
Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
granted A61KA61K31/4355A61K31/4365
Quick answer
US patent 11426420 (Inhibitors of short-chain dehydrogenase activity for treating coronary disorders) held by The Board of Regents of the University of Texas System expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4355, A61K31/4365, A61K31/437, A61K31/496